Kwanan nan, sanannen kamfanin cannabis na likitanci Little Green Pharma Ltd ya fitar da sakamakon bincike na watanni 12 na shirin gwaji na QUEST. Sakamakon binciken ya ci gaba da nuna ci gaba mai ma'ana na asibiti a cikin duk ingancin rayuwa mai alaƙa da lafiyar marasa lafiya (HRQL), matakan gajiya, da bacci. Bugu da ƙari, marasa lafiya da aka gano tare da waɗannan yanayi sun nuna haɓakar asibiti a cikin damuwa, damuwa, rashin barci, da ciwo.
Shirin gwaji na QUEST wanda aka ba da lambar yabo, wanda Little Green Pharma Ltd (LGP) ke ɗaukar nauyinsa, ɗaya ne daga cikin mafi girman karatun likitanci na dogon lokaci a duniya, yana bincika tasirin cannabis na likita akan ingancin rayuwar marasa lafiya. Jami'ar Sydney a Ostiraliya ta jagoranta, LGP ya ba wa mahalarta taron da rangwamen mai na maganin cannabis na Australiya. Waɗannan magungunan cannabis sun ƙunshi nau'ikan nau'ikan nau'ikan kayan aiki daban-daban, kodayake marasa lafiya da yawa sun yi amfani da tsarin CBD-kawai don kiyaye cancantar tuƙi yayin binciken.
Har ila yau, binciken ya sami tallafi daga mai inshorar lafiya mai zaman kansa mai zaman kansa HIF Australia, jagora daga gogaggun kwamitin shawarwari, da amincewa daga ƙungiyoyin ƙasa kamar MS Research Australia, Chronic Pain Australia, Arthritis Australia, da Epilepsy Australia. Sakamakon watanni 12 na shirin gwaji na QUEST an gudanar da bitar takwarorinsu kuma an buga su a cikin buɗaɗɗen mujallar shiga PLOS One.
Bayanin Gwaji
Tsakanin Nuwamba 2020 da Disamba 2021, shirin gwaji na QUEST ya gayyaci manyan majinyata na Australiya waɗanda sababbi ne ga cannabis na likitanci kuma suna fama da yanayi na yau da kullun kamar zafi, gajiya, rashin bacci, damuwa, da damuwa don shiga.
Mahalarta sun kasance daga 18 zuwa 97 (matsakaicin: 51), tare da 63% kasancewa mata. Mafi yawan yanayin da aka ruwaito sun kasance masu ciwo na musculoskeletal da ciwon neuropathic (63%), wanda ya biyo bayan rashin barci (23%), da rashin tausayi da damuwa (11%). Rabin mahalarta suna da cututtuka masu yawa.
Likitoci masu zaman kansu 120 a cikin jihohi shida sun dauki mahalarta aiki. Duk mahalarta sun kammala tambayoyin asali kafin su fara maganin cannabis na likita, sannan tambayoyin tambayoyi na gaba a makonni biyu sannan kowane watanni 1-2 sama da watanni 12. Musamman ma, cancanta da ake buƙata kafin gazawar jiyya ko illa daga daidaitattun magunguna.
Sakamakon Gwaji
Binciken watanni na 12 ya nuna shaida mai karfi (p<0.001) na ingantawa a cikin HRQL gaba ɗaya, barci, da gajiya tsakanin mahalarta. An kuma lura da taimako mai ma'ana na asibiti a cikin ƙungiyoyin da ke da damuwa, zafi, damuwa, da rashin barci. "Sakamako masu ma'ana a asibiti" yana nufin binciken da ke tasiri sosai ga lafiyar mutum ko jin daɗin rayuwa, mai yuwuwar canza fahimtar ƙwararrun kiwon lafiya ko hanyoyin jiyya.
Duk mahalarta sun bi ka'idar gwaji, shan magungunan cannabis na baka bayan rashin nasara kafin jiyya tare da daidaitattun hanyoyin kwantar da hankali. Binciken ya nuna kyakkyawan sakamako mai kyau na maganin cannabis guda ɗaya a cikin irin wannan yanayi mai faɗi. Waɗannan binciken na watanni 12 kuma sun tabbatar da farkon sakamakon gwajin QUEST na watanni 3 da aka buga a cikin PLOS One a cikin Satumba 2023.
Dokta Paul Long, Daraktan Likitoci na LGP, ya bayyana cewa: "Muna da matukar farin ciki da ci gaba da jagorantar binciken cannabis na likitanci tare da tallafawa wannan muhimmin gwaji kan tasirin rayuwar marasa lafiya. Wadannan sakamakon suna da mahimmanci musamman ga likitocin Ostiraliya, saboda sun tabbatar da ingancin maganin cannabis na Australiya ga marasa lafiya na gida."
Ya kara da cewa: "Ta hanyar amfani da kayayyakin da ake samarwa a cikin gida da kuma shigar da marasa lafiya a cikin gida, muna samar da bayanai masu mahimmanci don taimakawa likitoci su rubuta da kwarin gwiwa, daga ƙarshe inganta kula da marasa lafiya a duk faɗin ƙasar. Bayan fa'idodin kiwon lafiya, wannan binciken ya ba da damar samun ƙwararrun masu rubutawa da ƙarin magunguna masu araha - wani yunƙuri ya ci gaba da ci gaba a bincikenmu na QUEST Global."
Dokta Richard Norman, Mashawarcin Harkokin Tattalin Arziki na Lafiya don gwajin QUEST kuma Mataimakin Farfesa a Jami'ar Curtin, ya ce: "Waɗannan binciken suna da mahimmanci saboda sun nuna cewa cannabis na likita na iya taka muhimmiyar rawa wajen inganta sakamakon kiwon lafiya don yanayi na yau da kullum, maimakon yin aiki a matsayin maganin 'band-aid'. Sakamakon watanni 12 na gaskiya na duniya yana da alƙawarin, yana nuna cewa GP na iya zama kayan aiki mai mahimmanci ga marasa lafiya na gargajiya. Mahimmanci, fa'idodin sun bayyana daidai a cikin yanayi kamar zafi, damuwa, da al'amuran bacci, tare da ingantaccen tasiri akan sauran fannonin rayuwa. ”
Nikesh Hirani, Babban Jami'in Bayanai da Ba da Shawarwari a HIF, ya lura: "Sanya hannun jari a cikin ci gaba da bincike game da yuwuwar fa'idodin kiwon lafiyar cannabis na da mahimmanci ga membobinmu, ma'aikata, da sauran jama'a. Shekaru huɗu na gwaji sun ba da sakamako mai ƙarfafawa, tare da shaidar kimiyya ta QUEST da ke nuna kyakkyawan tasirinsa akan yanayin rashin ƙarfi da yawa - haɓakar da aka samu sama da watanni 12.
Ya kara da cewa: "Babban manufar HIF ita ce ta taimaka wa membobi samun damar zabin kiwon lafiya wanda zai inganta rayuwar su. Bayanai sun nuna karuwar kashi 38% a duk shekara a cikin mambobin da ke biyan kudaden maganin cannabis na likita, wanda ke nuna amincewa da yiwuwarsa a matsayin ingantaccen magani."
Game da Little Green Pharma
Little Green Pharma kamfani ne na duniya, haɗaɗɗen tsaye, kuma rarrabuwar kampanin cannabis na likitanci wanda ke yin aikin noma, samarwa, masana'antu, da rarrabawa. Tare da wuraren samarwa guda biyu a duk duniya, yana ba da samfuran cannabis na mallakar mallaka da farar alamar likitanci. Wurinsa na Danish yana ɗaya daga cikin manyan wuraren samar da maganin cannabis na GMP mafi girma a Turai, yayin da ginin Yammacin Australiya babban aiki ne na cikin gida wanda ya kware a cikin kayan aikin cannabis na hannu.
Duk samfuran sun cika ƙa'idodi da ƙa'idodin gwaji waɗanda Hukumar Kula da Magunguna ta Danish (MMA) da Hukumar Kula da Kaya ta Therapeutic (TGA). Tare da haɓaka kewayon samfura daban-daban na ma'auni mai aiki, Little Green Pharma yana ba da maganin cannabis ga Australia, Turai, da kasuwannin duniya. Kamfanin yana ba da fifiko ga samun damar haƙuri a kasuwannin duniya masu tasowa, yana shiga cikin ƙwazo a cikin ilimi, bayar da shawarwari, bincike na asibiti, da haɓaka tsarin isar da magunguna.
Lokacin aikawa: Afrilu-21-2025